The renal injury and inflammation caused by ischemia-reperfusion are reduced by genetic inhibition of TNF-αR1

A comparison with infliximab treatment

Rosanna Di Paola, Tiziana Genovese, Daniela Impellizzeri, Akbar Ahmad, Salvatore Cuzzocrea, Emanuela Esposito

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

The role of the tumor necrosis factor (TNF)-α in the pathophysiology of renal ischemia/reperfusion (I/R) injury is unclear. We investigate the effects of TNF-αR1 gene deletion and infliximab administration on the degree of renal injury induced by I/R. TNF-αR1 knockout (TNF-αR1KO) and wild-type (TNF-αWT) mice were subjected to bilateral renal artery occlusion (30 min) and reperfusion (24 h). Infliximab (10 mg/kg subcutaneously, s.c.) was administered 1 h before ischemia. At the end of experiments, urea, creatinine, γGT, and AST were measured to assess renal function and reperfusion injury. Markers of oxidative stress, pro-inflammatory mediators, iNOS, COX-2, and NF-κB signaling pathway were measured. Kidney myeloperoxidase (MPO) activity and malondialdehyde (MDA) levels were measured to study polymorphonuclear cell infiltration and lipid peroxidation. TNF-αR1 gene deletion and infliximab administration prevented the increase of urea, creatinine, γGT, kidney AST levels, iNOS and COX-2 expression, NF-κB translocation, MPO activity and MDA levels. TNF-αR1 gene deletion and infliximab administration lowered the histological evidence of renal damage associated with I/R and caused a reduction of nitrotyrosine suggesting reduced nitrosative stress. Our results demonstrate that TNF-α plays an important role in I/R injury and put forward the hypothesis that modulation of TNF-α expression may represent a novel and possible strategy.

Original languageEnglish (US)
Pages (from-to)134-146
Number of pages13
JournalEuropean Journal of Pharmacology
Volume700
Issue number1-3
DOIs
StatePublished - Jan 30 2013
Externally publishedYes

Fingerprint

Reperfusion
Ischemia
Tumor Necrosis Factor-alpha
Inflammation
Kidney
Wounds and Injuries
Gene Deletion
Reperfusion Injury
Malondialdehyde
Peroxidase
Urea
Creatinine
Renal Artery
Infliximab
Knockout Mice
Lipid Peroxidation
Oxidative Stress

Keywords

  • Inflammation
  • Renal ischemia-reperfusion injury
  • TNF-αR1 gene deletion

ASJC Scopus subject areas

  • Pharmacology

Cite this

The renal injury and inflammation caused by ischemia-reperfusion are reduced by genetic inhibition of TNF-αR1 : A comparison with infliximab treatment. / Di Paola, Rosanna; Genovese, Tiziana; Impellizzeri, Daniela; Ahmad, Akbar; Cuzzocrea, Salvatore; Esposito, Emanuela.

In: European Journal of Pharmacology, Vol. 700, No. 1-3, 30.01.2013, p. 134-146.

Research output: Contribution to journalArticle

Di Paola, Rosanna ; Genovese, Tiziana ; Impellizzeri, Daniela ; Ahmad, Akbar ; Cuzzocrea, Salvatore ; Esposito, Emanuela. / The renal injury and inflammation caused by ischemia-reperfusion are reduced by genetic inhibition of TNF-αR1 : A comparison with infliximab treatment. In: European Journal of Pharmacology. 2013 ; Vol. 700, No. 1-3. pp. 134-146.
@article{bb510c07edbf4eab91862efc4b0664a0,
title = "The renal injury and inflammation caused by ischemia-reperfusion are reduced by genetic inhibition of TNF-αR1: A comparison with infliximab treatment",
abstract = "The role of the tumor necrosis factor (TNF)-α in the pathophysiology of renal ischemia/reperfusion (I/R) injury is unclear. We investigate the effects of TNF-αR1 gene deletion and infliximab administration on the degree of renal injury induced by I/R. TNF-αR1 knockout (TNF-αR1KO) and wild-type (TNF-αWT) mice were subjected to bilateral renal artery occlusion (30 min) and reperfusion (24 h). Infliximab (10 mg/kg subcutaneously, s.c.) was administered 1 h before ischemia. At the end of experiments, urea, creatinine, γGT, and AST were measured to assess renal function and reperfusion injury. Markers of oxidative stress, pro-inflammatory mediators, iNOS, COX-2, and NF-κB signaling pathway were measured. Kidney myeloperoxidase (MPO) activity and malondialdehyde (MDA) levels were measured to study polymorphonuclear cell infiltration and lipid peroxidation. TNF-αR1 gene deletion and infliximab administration prevented the increase of urea, creatinine, γGT, kidney AST levels, iNOS and COX-2 expression, NF-κB translocation, MPO activity and MDA levels. TNF-αR1 gene deletion and infliximab administration lowered the histological evidence of renal damage associated with I/R and caused a reduction of nitrotyrosine suggesting reduced nitrosative stress. Our results demonstrate that TNF-α plays an important role in I/R injury and put forward the hypothesis that modulation of TNF-α expression may represent a novel and possible strategy.",
keywords = "Inflammation, Renal ischemia-reperfusion injury, TNF-αR1 gene deletion",
author = "{Di Paola}, Rosanna and Tiziana Genovese and Daniela Impellizzeri and Akbar Ahmad and Salvatore Cuzzocrea and Emanuela Esposito",
year = "2013",
month = "1",
day = "30",
doi = "10.1016/j.ejphar.2012.11.066",
language = "English (US)",
volume = "700",
pages = "134--146",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - The renal injury and inflammation caused by ischemia-reperfusion are reduced by genetic inhibition of TNF-αR1

T2 - A comparison with infliximab treatment

AU - Di Paola, Rosanna

AU - Genovese, Tiziana

AU - Impellizzeri, Daniela

AU - Ahmad, Akbar

AU - Cuzzocrea, Salvatore

AU - Esposito, Emanuela

PY - 2013/1/30

Y1 - 2013/1/30

N2 - The role of the tumor necrosis factor (TNF)-α in the pathophysiology of renal ischemia/reperfusion (I/R) injury is unclear. We investigate the effects of TNF-αR1 gene deletion and infliximab administration on the degree of renal injury induced by I/R. TNF-αR1 knockout (TNF-αR1KO) and wild-type (TNF-αWT) mice were subjected to bilateral renal artery occlusion (30 min) and reperfusion (24 h). Infliximab (10 mg/kg subcutaneously, s.c.) was administered 1 h before ischemia. At the end of experiments, urea, creatinine, γGT, and AST were measured to assess renal function and reperfusion injury. Markers of oxidative stress, pro-inflammatory mediators, iNOS, COX-2, and NF-κB signaling pathway were measured. Kidney myeloperoxidase (MPO) activity and malondialdehyde (MDA) levels were measured to study polymorphonuclear cell infiltration and lipid peroxidation. TNF-αR1 gene deletion and infliximab administration prevented the increase of urea, creatinine, γGT, kidney AST levels, iNOS and COX-2 expression, NF-κB translocation, MPO activity and MDA levels. TNF-αR1 gene deletion and infliximab administration lowered the histological evidence of renal damage associated with I/R and caused a reduction of nitrotyrosine suggesting reduced nitrosative stress. Our results demonstrate that TNF-α plays an important role in I/R injury and put forward the hypothesis that modulation of TNF-α expression may represent a novel and possible strategy.

AB - The role of the tumor necrosis factor (TNF)-α in the pathophysiology of renal ischemia/reperfusion (I/R) injury is unclear. We investigate the effects of TNF-αR1 gene deletion and infliximab administration on the degree of renal injury induced by I/R. TNF-αR1 knockout (TNF-αR1KO) and wild-type (TNF-αWT) mice were subjected to bilateral renal artery occlusion (30 min) and reperfusion (24 h). Infliximab (10 mg/kg subcutaneously, s.c.) was administered 1 h before ischemia. At the end of experiments, urea, creatinine, γGT, and AST were measured to assess renal function and reperfusion injury. Markers of oxidative stress, pro-inflammatory mediators, iNOS, COX-2, and NF-κB signaling pathway were measured. Kidney myeloperoxidase (MPO) activity and malondialdehyde (MDA) levels were measured to study polymorphonuclear cell infiltration and lipid peroxidation. TNF-αR1 gene deletion and infliximab administration prevented the increase of urea, creatinine, γGT, kidney AST levels, iNOS and COX-2 expression, NF-κB translocation, MPO activity and MDA levels. TNF-αR1 gene deletion and infliximab administration lowered the histological evidence of renal damage associated with I/R and caused a reduction of nitrotyrosine suggesting reduced nitrosative stress. Our results demonstrate that TNF-α plays an important role in I/R injury and put forward the hypothesis that modulation of TNF-α expression may represent a novel and possible strategy.

KW - Inflammation

KW - Renal ischemia-reperfusion injury

KW - TNF-αR1 gene deletion

UR - http://www.scopus.com/inward/record.url?scp=84872921643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872921643&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2012.11.066

DO - 10.1016/j.ejphar.2012.11.066

M3 - Article

VL - 700

SP - 134

EP - 146

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -